Ukraine was pharma's clinical trial 'darling.' As war drags on, will the industry return?
BioPharma
Source: biopharmadive.com
Andreas Muehler News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Andreas Muehler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Andreas Muehler Today - Breaking & Trending Today
Immunic to Host MS R&D Day and Participate in Investor Conferences in April
NEW YORK, April 4, 2024 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and...
Source: marketscreener.com
EQS-News: Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
Issuer: Immunic, Inc. / Key word(s): Study results Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis 09.10.2023 / 22:01 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Reports Positi...
Source: boersennews.de
Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
– 24-Week Data from First Half of Patients Shows Improvements in Biomarker NfL, Consistent Throughout the Overall Progressive Multiple Sclerosis P...
Source: businessinsider.com
Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...
Source: prnewswire.com